Drugs Made In America Acquisition Corp. 425 Filing
Ticker: DMAA · Form: 425 · Filed: May 5, 2026 · CIK: 0002028614
| Field | Detail |
|---|---|
| Company | Drugs Made In America Acquisition Corp. (DMAA) |
| Form Type | 425 |
| Filed Date | May 5, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 425 filing submitted by Drugs Made In America Acquisition Corp. (ticker: DMAA) to the SEC on May 5, 2026.
Where can I view the full 425 filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Form 425 (Form 425) was filed with the SEC on May 5, 2026 regarding Drugs Made In America Acquisition Corp. (DMAA).